Scopolamine clinical trials
Also written Hyoscine.
Includes 6 studies of DPI-386.
How each study uses Scopolamine is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the Scopolamine studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- 31 Dec 1979 · TRANSDERM SCOP · NDA 017874 (FDA, Drugs@FDA)
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
45 studies that test it; most in 2016 (6)
| Year | Studies |
|---|---|
| 2003 | 1 |
| 2004 | 1 |
| 2005 | 1 |
| 2006 | 1 |
| 2008 | 1 |
| 2009 | 1 |
| 2010 | 2 |
| 2011 | 1 |
| 2013 | 2 |
| 2014 | 4 |
| 2015 | 2 |
| 2016 | 6 |
| 2017 | 4 |
| 2018 | 3 |
| 2019 | 6 |
| 2020 | 1 |
| 2021 | 3 |
| 2022 | 3 |
| 2025 | 2 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 17 · Other 28
Repurposed Therapeutics, Inc. (11) · Medical Corps, Israel Defense Force (2) · National Institute of Mental Health (NIMH) (2) · Massachusetts General Hospital (2) · Dartmouth-Hitchcock Medical Center (1) · Dr. Brian Hallahan (1) · Stony Brook University (1) · Rutgers, The State University of New Jersey (1)
Often tested with
Tested in the same studies.
Propofol (3) · Ketamine (3) · Meclizine (2) · Aprepitant (2) · Dexmedetomidine (2) · Fentanyl (2) · Sevoflurane (2) · Desflurane (2)
Related medicines
As reviewed, each with the page that says it.
- One of Antiemetics source
- One of Cholinergic Antagonists source
- One of Antimuscarinics source
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 1
Studies that test Scopolamine.
- Nov 2027Pharmacological Modulation of Brain Oscillations in Memory ProcessingEarly Phase 1 · University of Texas Southwestern Medical Center
Studies
Open first, then newest update. How each study uses Scopolamine is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 45
- Pharmacological Modulation of Brain Oscillations in Memory ProcessingRecruitingEarly Phase 1University of Texas Southwestern Medical CenterNCT05594017Written as Scopolamine (0.4mg)
- Representation of Spatiotemporal Information in Human Episodic Memory and NavigationEnrolling by invitationEarly Phase 1University of ArizonaNCT07423923Written as Scopolamine
- Combination of Intranasal Scopolamine and Sensory Augmentation to Mitigate G-transition Induced Motion Sickness and Enhance Sensorimotor PerformanceRecruitingPhase 2Repurposed Therapeutics, Inc.NCT05886660Written as DPI-386 Nasal Gel
- Combination of Intranasal Scopolamine and Sensory Augmentation to Mitigate G-transition Induced Motion Sickness and Enhance Sensorimotor PerformanceRecruitingPhase 2Repurposed Therapeutics, Inc.NCT05852730Written as DPI-386 Nasal Gel
- Motion Sickness Medications and Vestibular Time ConstantCompletedPhase 4Medical Corps, Israel Defense ForceNCT03270839Written as Kwells
- Nebulizer Delivery of Intranasal ScopolamineCompletedPhase 1Dartmouth-Hitchcock Medical CenterNCT04999449Written as Scopolamine
- PET and MRI Imaging With Scopolamine at the Muscarinic M1 ReceptorWithdrawnPhase 1Yale UniversityNCT06014385Written as Scopolamine
- Scopolamine in Bipolar DepressionCompletedPhase 2Dr. Brian HallahanNCT04211961Written as Scopolamine
- Designing Optimal Prevention and Management of Postoperative Nausea and Emesis for Patients Undergoing Laparoscopic Sleeve GastrectomyCompletedPhase 4Stony Brook UniversityNCT03435003Written as scopolamine transdermal
- Prevention and Treatment of Nausea Associated With Motion Sickness in Senior SubjectsCompletedPhase 3Repurposed Therapeutics, Inc.NCT03988530Written as Scopolamine
- Efficacy and Safety of DPI-386 Nasal Gel for the Prevention of Nausea and Vomiting Associated With MotionCompletedPhase 3Repurposed Therapeutics, Inc.NCT05548270Written as DPI-386 Nasal Gel
- Scopolamine Patch and Acupressure Point P6 Stimulation for Reduction of Nausea and Vomiting During Cesarean SectionCompletedPhase 4Rutgers, The State University of New JerseyNCT02960113Written as scopolamine patch
- Nasal Gel for the Prevention of Nausea and Vomiting Associated With MotionCompletedPhase 3Repurposed Therapeutics, Inc.NCT04947423Written as DPI-386 Nasal Gel
- Cholinergic Modulation of Condition and Emotion in Mood Disorders: Functional Neuroimaging StudiesTerminatedPhase 2National Institute of Mental Health (NIMH)NCT00055575Written as Scopolamine Nasal Spray
- The Safety and Effectiveness of Cholinergic Receptor Block Therapy in the Treatment of ALSStatus unknownPhase 2Ruijin HospitalNCT04391361Written as Scopolamine, atropine, edaravone and dexmedetomidine
- Scopolamine in Healthy VolunteersStatus unknownPhase 1Repurposed Therapeutics, Inc.NCT03874130Written as Scopolamine
- Nasal Gel Under Military Operational Conditions for the Prevention of Nausea Associated With Motion SicknessStatus unknownPhase 3Repurposed Therapeutics, Inc.NCT04272255Written as scopolamine HBr
- DPI 386 Nasal Gel for the Prevention of Nausea Associated With Motion SicknessTerminatedPhase 2/3Repurposed Therapeutics, Inc.NCT04219982Written as DPI-386 Nasal Gel
- Nasal Gel for the Prevention and Treatment of Nausea Associated With Motion SicknessCompletedPhase 3Repurposed Therapeutics, Inc.NCT04184115Written as DPI-386 Nasal Gel
- The Prevention and Treatment of Nausea Associated With Motion SicknessCompletedPhase 3Repurposed Therapeutics, Inc.NCT03986905Written as Scopolamine Nasal Gel
See all 45 studies that test Scopolamine →
Given beside what is tested · 4 — Scopolamine is usual care or a partner of the new treatment
- Multimodal Analgesia Effect on Post Surgical PatientCompletedPhase 4University of California, DavisNCT04240626Written as Scopolamine patch
- The INCREASE Study - Delaying the Onset of Alzheimer's Symptomatic ExpressionCompletedEarly Phase 1Daniela MogaNCT02849639Written as Scopolamine patch
- Comparison of Aprepitant Versus Aprepitant and Transdermal Scopolamine for Preventing Postoperative Nausea and VomitingCompletedNot applicableDrexel UniversityNCT00717054Written as Scopolamine
- Assessment of Cholinergic and Cognitive Function Using Pharmacologic ASL-Perfusion MRICompletedNot applicableHebrew SeniorLifeNCT01379001Written as Scopolamine
As the comparator · 4 — what is tested is compared with Scopolamine
- Evaluation of the Efficacy of the Injection of Botulinum Toxin A vs Scopolamine Patches in the Treatment of Drooling in Children With Cerebral PalsyTerminatedPhase 3Hospices Civils de LyonNCT03616067Written as Scopoderm® patches arm
- Efficacy and Safety of Escócia Association in the Treatment of Acute PainWithdrawnPhase 2EMSNCT04666701Written as Scopolamine
- Lumbar Spine Manipulation Versus Pharmacological Therapy in Young Women With Primary DysmenorrheaCompletedNot applicableUniversity of AlcalaNCT04866355Written as Hyoscine and Ibuprofen
- Effect of Buscopan on Gastrointestinal Imaging Quality With Probe-based Confocal Laser EndomicroscopyStatus unknownNot applicableXijing Hospital of Digestive DiseasesNCT02725398Written as Scopolamine
Codes
What other systems call Scopolamine · ClinicalTrials.gg INT008184
- MeSH (NLM) D012601ScopolamineConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) DL48G20X8XSCOPOLAMINEConfirmed FDA, NLM, Wikidata
- RxNorm 9601Confirmed FDA, Wikidata
- Wikidata Q337188L-scopolamineConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C47712ScopolamineOne source FDA
- DrugBank DB00747One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D012601 | Scopolamine | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | DL48G20X8X | SCOPOLAMINE | Confirmed FDA, NLM, Wikidata |
| RxNorm | 9601 | — | Confirmed FDA, Wikidata |
| Wikidata | Q337188 | L-scopolamine | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C47712 | Scopolamine | One source FDA |
| DrugBank | DB00747 | — | One source Wikidata |
Also registered as scopolamine hydrobromide (UNII 451IFR0GXB · RxNorm 9603).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.